Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial. - Mercer LD; Seña AC; Colgate ER; Crothers JW; Wright PF; Al-Ibrahim M; Tritama E; Vincent A; Mainou BA; Zhang Y; Konopka-Anstadt J; Bandyopadhyay AS; et al. (The Lancet. Infectious diseases, 2025)